Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (clinical-population study)
https://doi.org/10.17650/1994-4098-2024-20-4-33-43
Abstract
Background. Malignant neoplasms of the vulva account for about 4 % of all gynecological cancer neoplasms. Every year in Russia more than 2000 new cases of vulvar cancer are registered, in the North-Western Federal Region of Russia (NWFRR)1 – more than 200 (2022). The incidence rate for Russia as a whole is within 2.5 cases per 100,000 female population (in the NWFRR – about 3,00/0000). Standardized incidence rates for Russia and the NWFRR are within 1.1 and 1.20/0000. Before the age of 30, vulvar cancer practically does not occur; the maximum number (200–300) of cases is registered mainly among women over 60 years of age. There is no information on the mortality rate of the female population for this cancer localization in Russia, as well as calculations of such analytical indicators as mortality and patient survival, information about which can only be obtained on the basis of databases of individual population cancer registries.
Aim. To study the prevalence of vulvar cancer based on the newly created population cancer registries database of the NWFRR, to consider the detailed structure of this tumor localization taking into account the fourth digit of the International Classification of Diseases-10, the histological structure of tumors, and the calculation of one-year and five-year patient survival.
Materials and methods. The research material is data from the International Agency for Research on Cancer, reference books P.A. Herzen National Medical Research Center of Oncology and National Medical Research Oncology Center, databases of population cancer registries of Saint Petersburg and the NWFRR. Data processing was carried out using licensed programs MS Excel 2013–2016 and Statistica 6.1. To calculate survival, a modified Eurocare program was used, as well as mathematical, bibliographic and statistical methods.
Results and conclusion. The first population-based study of the prevalence and effectiveness of anti-cancer measures based on the population cancer registries database, conducted in Russia, showed an increase in morbidity among the female population of malignant tumors of the vulva, decreased mortality of patients at each year of observation. The one-year relative survival rate of patients with vulvar cancer reached 72.0 %, five-year – 41.8 %. One-year survival rate by stage of the disease: I stage – 91.6 %, II stage – 79.7 %, III stage – 53.1 %, IV stage – 29.0 %. Five-year survival rate by stage of the disease: I stage – 68.2 %, II stage – 46.7 %, III stage – 18.6 %, IV stage – 5.6 %.
About the Authors
V. M. MerabishviliRussian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia
I. V. Berlev
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia;
41 Kirochnaya St., Saint Petersburg 191015, Russia
A. F. Urmancheeva
Russian Federation
Adel Fedorovna Urmancheeva
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia;
41 Kirochnaya St., Saint Petersburg 191015, Russia
E. V. Bakhidze
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia
E. A. Ulrikh
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758, Russia;
41 Kirochnaya St., Saint Petersburg 191015, Russia;
2 Akkuratova St., Saint Petersburg 197341, Russia
References
1. Urmancheeva A.F. Epidemiology of vulvar cancer. Risk and prognosis factors. Prakticheskaya onkologiya = Practical Oncology 2006;7(4):189–96. (In Russ.).
2. Ilyin A.A., Khadzhimba A.S., Maksimov S.Ya. et al. Minimal vulvar cancer: Literature review and own clinical observations. Opukholi zhenskoy reproduktivnoy sistemy = Tumors of Female Reproductive System 2018;14(3):64–70. (In Russ.).
3. Murshudova S.Kh., Chulkova O.V., Filonenko E.V. Classification, etiology, pathogenesis and diagnostics of precancer and initial cancer of the vulva. Onkologiya. Zhurnal im. P.A. Gertzena = Oncology. P.A. Herzen Journal 2013;2(1):63–7. (In Russ.).
4. Bokhman Y.V., Tadzhibaeva Yu., Neishtadt E.L. et al. Cancer of the vulva. Tashkent, 1996. 184 p. (In Russ.).
5. Kuznetsov V.V., Mekhtiev V.N., Korzhevskaya E.V. et al. Vulvar cancer: Prognostic factors, treatment. Sovremennaya onkologiya = Modern Oncology 2000;2(2):37–9. (In Russ.).
6. Bohman Ya.V. Handbook of Oncogynecology. Leningrad: Meditsina, 1989. 464 p. (In Russ.).
7. Cancer Incidence in Five Continents. Volume XII. Registry Summary Tables. Available at: https://ci5.iarc.fr/ci5-xii/tables/summary.
8. Malignant neoplasms in Russia in 2022 (incidence and mortality). Ed. by A.D. Kaprin et al. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2023. 275 p. (In Russ.).
9. Merabishvili V.M. Malignant neoplasms in the Northwestern Federal District of Russia (morbidity, mortality, reliability of registration, survival of patients). Express information. Issue 6. Manual for doctors. Ed. by Corresponding Member of the Russian Academy of Sciences, Prof. A.M. Belyaev. Sant Petersburg, 2023. 283 p. (In Russ.).
10. Malignant neoplasms in Russia in 2011 (morbidity and mortality). Edited by V.I. Chissov, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2013. 289 p. (In Russ.).
11. Malignant neoplasms in Russia in 2015 (incidence and mortality). Ed. by A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2017. 250 p. (In Russ.).
12. Malignant neoplasms in Russia in 2019 (incidence and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2020. 214 p. (In Russ.).
13. Malignant neoplasms in Russia in 2020 (incidence and mortality). Ed. by A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2021. 252 p. (In Russ.).
14. Malignant neoplasms in Russia in 2021 (incidence and mortality). Ed. by A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022. 252 p. (In Russ.).
15. Handbook of comparison of codes of the international classification of diseases 9th and 10th revisions by class of neoplasms. Ed. by V.M. Merabishvili. Saint Petersburg, 1997. 92 p. (In Russ.).
16. Merabishvili V.M. Medical and statistical terminology dictionary: a methodological manual for doctors, residents, postgraduate students and researchers. 2nd edn. Saint Petersburg: Izdatelskie tekhnologii, 2021. 120 p. (In Russ.).
17. Survival of cancer patients in Europe: The EUROCARE Study (IARC Scientific Publications No. 132). Ed. by F. Berrino et al. Lyon: International Agency for Research on Cancer, 1995.
18. Survival of cancer patients in Europe: The EUROCARE-2 study (IARC Scientific Publications No. 151). Ed. by F. Berrino et al. Lyon: International Agency for Research on Cancer, 1999.
19. Berrino F., Capocaccia R., Esteve J. et al. EUROCARE-3: The survival of cancer patients diagnosed in Europe during 1990–94. Ann Oncol 2003;14(Suppl 5):1–155.
20. Capocaccia R., Gavin A., Hakulinen T. et al. Survival of cancer patients in Europe, 1995–2002. The EUROCARE-4 study. Eur J Cancer 2009;45.
21. De Angelis R., Sant M., Coleman M. et al. Cancer survival in Europe 1999–2007 by country and age: Results of EUROCARE-5 – a population-based study. Lancet Oncol 2014;15:23–34. DOI: 10.1016/ S1470-2045(13)70546-1
22. Merabishvili V.M. Survival of cancer patients. Vol. 2, part I. Saint Petersburg: KOSTA, 2011. 332 p. (In Russ.).
23. Merabishvili V.M. Survival of cancer patients. 2nd edn, part II. Ed. By Yu.A. Shcherbuk. Saint Petersburg: KOSTA, 2011. 408 p. (In Russ.).
24. Merabishvili V.M. Malignant neoplasms in the North-Western Federal District of Russia (incidence, mortality, reliability of accounting, patient survival). Express information. Issue 5. Ed. by Prof. A.M. Belyaev, Prof. A.M. Shcherbakov. Saint Petersburg: Izdatelskie tekhnologii, 2020. (In Russ.).
25. Oncogynecology: Anational guideline. Ed. by A.D. Kaprin, L.A. Ashrafyan, I.S. Stilidi. Moscow: GEOTAR-Media, 2019. 384 p. (In Russ.).
Review
For citations:
Merabishvili V.M., Berlev I.V., Urmancheeva A.F., Bakhidze E.V., Ulrikh E.A. Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (clinical-population study). Tumors of female reproductive system. 2024;20(4):33-43. (In Russ.) https://doi.org/10.17650/1994-4098-2024-20-4-33-43